Optimizing CIGB-300 intralesional delivery in locally advanced cervical cancer (Q27332192)

25 June 2017

title

Optimizing CIGB-300 intralesional delivery in locally advanced cervical cancer (English)

1 reference

25 June 2017

main subject

cervix uterine cancer

1 reference

M R Sarduy

1

M R

Sarduy

1 reference

25 June 2017

I García

2

I

García

1 reference

25 June 2017

M A Coca

3

M A

Coca

1 reference

25 June 2017

A Perera

4

A

Perera

1 reference

25 June 2017

L A Torres

5

L A

Torres

1 reference

25 June 2017

C M Valenzuela

6

C M

Valenzuela

1 reference

25 June 2017

I Baladrón

7

I

Baladrón

1 reference

25 June 2017

M Solares

8

M

Solares

1 reference

25 June 2017

V Reyes

9

V

Reyes

1 reference

25 June 2017

I Hernández

10

I

Hernández

1 reference

25 June 2017

Y Perera

11

Y

Perera

1 reference

25 June 2017

Y M Martínez

12

Y M

Martínez

1 reference

25 June 2017

L Molina

13

L

Molina

1 reference

25 June 2017

Y M González

14

Y M

González

1 reference

25 June 2017

J A Ancízar

15

J A

Ancízar

1 reference

25 June 2017

A Prats

16

A

Prats

1 reference

25 June 2017

L González

17

L

González

1 reference

25 June 2017

C A Casacó

18

C A

Casacó

1 reference

25 June 2017

B E Acevedo

19

B E

Acevedo

1 reference

25 June 2017

P A López-Saura

20

P A

López-Saura

1 reference

25 June 2017

D F Alonso

21

D F

Alonso

1 reference

25 June 2017

R Gómez

22

R

Gómez

1 reference

25 June 2017

S E Perea-Rodríguez

23

S E

Perea-Rodríguez

1 reference

25 June 2017

CERVIFARM-300-II Study Group

24

1 reference

25 June 2017

language of work or name

English

0 references

publication date

16 April 2015

1 reference

British Journal of Cancer

25 June 2017

published in

1 reference

25 June 2017

volume

112

1 reference

25 June 2017

issue

10

1 reference

25 June 2017

page(s)

1636-1643

1 reference

Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International

25 June 2017

copyright license

start time

16 April 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

describes a project that uses

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC4430720/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

cites work

Antitumor activity of pyridocarbazole and benzopyridoindole derivatives that inhibit protein kinase CK2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4430720

Statistical design considerations for pilot studies transitioning therapies from the bench to the bedside

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4430720

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4430720

Synergistic interactions of the anti-casein kinase 2 CIGB-300 peptide and chemotherapeutic agents in lung and cervical preclinical cancer models

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4430720

Protein kinase CK2 in hematologic malignancies: reliance on a pivotal cell survival regulator by oncogenic signaling pathways

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4430720

CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4430720

CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4430720

Proteomic profile regulated by the anticancer peptide CIGB-300 in non-small cell lung cancer (NSCLC) cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4430720

Safety and preliminary efficacy data of a novel casein kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4430720

Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4430720

CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4430720

Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4430720

Systemic administration of a peptide that impairs the protein kinase (CK2) phosphorylation reduces solid tumor growth in mice.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4430720

Targeting CK2 for cancer therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4430720

Antitumor effect of a novel proapoptotic peptide that impairs the phosphorylation by the protein kinase 2 (casein kinase 2).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4430720

MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4430720

Role of Protein Phosphorylation in Post-translational Regulation of Protein B23 during Programmed Cell Death in the Prostate Gland

28 September 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25880012

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.2015.137

1 reference

Dimensions Publication ID

25 June 2017

1006458970

0 references

OpenCitations bibliographic resource ID

4912790

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4912790

1 reference